| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |